Edit |   |
---|---|
Antigenic Specificity | CD116, Human (Mavrilimumab biosimilar) |
Clone | Mavrilimumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 lambda2 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD116 Recombinant Antibody. Mavrilimumab is a human monoclonal antibody[1] that inhibits human granulocyte macrophage colony-stimulating factor receptor (GM-CSF-R). Mavrilimumab was discovered as CAM-3001 by Cambridge Antibody Technology and is being developed by MedImmune, Inc. as an investigational drug for the treatment of rheumatoid arthritis. |
Immunogen | n/a |
Other Names | Anti-CD116 Recombinant Antibody, Research Grade Mavrilimumab, Anti-Human CD116 Recombinant Antibody, CAM-3001, Antibody Drug Analogues, Monoclonal Antibody, YR1227, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1085337-57-0 |
Catalog # | YR1227 |
Price | please inquire |
Order / More Info | CD116, Human (Mavrilimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |